These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15954860)

  • 21. Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective.
    Barriere SL
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S4-9. PubMed ID: 20597670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial treatment of ventilator-associated pneumonia.
    Park DR
    Respir Care; 2005 Jul; 50(7):932-52; discussion 952-5. PubMed ID: 15972114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of de-escalating antimicrobial therapy in patients with ventilator-associated pneumonia.
    Niederman MS
    Semin Respir Crit Care Med; 2006 Feb; 27(1):45-50. PubMed ID: 16508881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B.
    Pereira GH; Muller PR; Levin AS
    Diagn Microbiol Infect Dis; 2007 Jun; 58(2):235-40. PubMed ID: 17350201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of gram-negative bacteria in healthcare-associated pneumonia.
    Restrepo MI; Anzueto A
    Semin Respir Crit Care Med; 2009 Feb; 30(1):61-6. PubMed ID: 19199188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia.
    Kiem S; Schentag JJ
    Semin Respir Crit Care Med; 2006 Feb; 27(1):51-67. PubMed ID: 16508882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery of topical antibiotics: pharmacokinetics and clinical problems.
    Ilowite JS; Niederman MS; Fein AM
    Semin Respir Infect; 1991 Sep; 6(3):158-67. PubMed ID: 1754736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Selective digestive tract decontamination in intensive care medicine. Fundamentals and current evaluation].
    Krueger WA; Heininger A; Unertl KE
    Anaesthesist; 2003 Feb; 52(2):142-52. PubMed ID: 12624700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The invasive (quantitative) diagnosis of ventilator-associated pneumonia.
    Chastre J; Combes A; Luyt CE
    Respir Care; 2005 Jun; 50(6):797-807; discussion 807-12. PubMed ID: 15913470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and antimicrobial therapy of pneumonia caused by continuous mechanical ventilation after cardiosurgery].
    Popov DA; Vostrikova TIu
    Anesteziol Reanimatol; 2010; (5):72-7. PubMed ID: 21395147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and management.
    Tacconelli E; De Angelis G
    Curr Opin Pulm Med; 2009 May; 15(3):218-22. PubMed ID: 19373090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit.
    McMullin BB; Chittock DR; Roscoe DL; Garcha H; Wang L; Miller CC
    Respir Care; 2005 Nov; 50(11):1451-6. PubMed ID: 16253152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of nursing home-acquired pneumonia.
    Mills K; Graham AC; Winslow BT; Springer KL
    Am Fam Physician; 2009 Jun; 79(11):976-82. PubMed ID: 19514695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative evaluation of empirical antibacterial therapy for ventilator-associated pneumonia].
    Mkhoian GG; Akopian GP
    Anesteziol Reanimatol; 2006; (2):57-61. PubMed ID: 16758947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is healthcare-associated pneumonia, and how should it be treated?
    Craven DE
    Curr Opin Infect Dis; 2006 Apr; 19(2):153-60. PubMed ID: 16514340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial treatment of lower respiratory tract infections in the hospital setting.
    Grossman RF; Rotschafer JC; Tan JS
    Am J Med; 2005 Jul; 118 Suppl 7A():29S-38S. PubMed ID: 15993675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.